ArticleNPJ digital medicine2024
Multimodal digital phenotyping of diet, physical activity, and glycemia in Hispanic/Latino adults with or at risk of type 2 diabetes.
Article in NPJ digital medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 23 citations in OpenAlex.
- Software Reference Architecture for Real-Time Mobile Digital Phenotyping: Evaluation of System Designs.JMIR formative research · 2026Article
- Dietary Behavior, Physical Activity, and 24-Hour Rhythm Coherence: A Digital Phenotyping Perspective on Vascular and Glycemic Health.Nutrients · 2026Review
- Temporal Changes in Continuous Glucose Monitoring Profiles in Health Care Workers Participating in a Digitally Delivered Metabolic Wellness Program.Journal of diabetes science and technology · 2026Article
- Stakeholder Perspectives on Humanistic Implementation of Computer Perception in Health Care: Qualitative Study.JMIR mental health · 2026Article
- Review
- Continuous Glucose Monitoring to Guide Lifestyle Choices With a Focus on Nutrition in the Management of Type 2 Diabetes: A Systematic Review and Meta-Analysis.Journal of diabetes science and technology · 2025Review
- Investigating the needs of older adults with type 2 diabetes and conceptualizing a healthy diet management application: a conceptual design.BMC geriatrics · 2025Article
- Artificial intelligence in glycemic management for diabetes: Applications, opportunities and challenges.Journal of translational internal medicine · 2025Article
- Weight loss is associated with improved daytime time in range in adults with prediabetes and non-insulin-treated type 2 diabetes undergoing dietary intervention.Diabetic medicine : a journal of the British Diabetic Association · 2025Article
- A deep learning framework for virtual continuous glucose monitoring and glucose prediction based on life-log data.Scientific reports · 2025Article
- User-Centred Design and Development of a Smartphone Application (Healthcare (Basel, Switzerland) · 2024Article
- Technology and health inequities in diabetes care: How do we widen access to underserved populations and utilize technology to improve outcomes for all?Diabetes, obesity & metabolism · 2024Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Digital phenotyping refers to characterizing human bio-behavior through wearables, personal devices, and digital health technologies. Digital phenotyping in populations facing a disproportionate burden of type 2 diabetes (T2D) and health disparities continues to lag compared to other populations. Here, we report our study demonstrating the application of multimodal digital phenotyping, i.e., the simultaneous use of CGM, physical activity monitors, and meal tracking in Hispanic/Latino individuals with or at risk of T2D. For 14 days, 36 Hispanic/Latino adults (28 female, 14 with non-insulin treated T2D) wore a continuous glucose monitor (CGM) and a physical activity monitor (Actigraph) while simultaneously logging meals using the MyFitnessPal app. We model meal events and daily digital biomarkers representing diet, physical activity choices, and corresponding glycemic response. We develop a digital biomarker for meal events that differentiates meal events into normal and elevated categories. We examine the contribution of daily digital biomarkers of elevated meal event count and step count on daily time-in-range 54-140 mg/dL (TIR
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.